67 related articles for article (PubMed ID: 9880915)
1. Selective inhibition of Src protein tyrosine kinase by analogues of 5-S-glutathionyl-beta-alanyl-L-dopa.
Zheng ZB; Nagai S; Iwanami N; Kobayashi A; Hijikata M; Natori S; Sankawa U
Chem Pharm Bull (Tokyo); 1998 Dec; 46(12):1950-1. PubMed ID: 9880915
[TBL] [Abstract][Full Text] [Related]
2. Inhibition effects of 5-S-glutathionyl-N-beta-alanyl-L-dopa analogues against Src protein tyrosine kinase.
Zheng ZB; Nagai S; Iwanami N; Kobayashi A; Natori S; Sankawa U
Chem Pharm Bull (Tokyo); 1999 Jun; 47(6):777-82. PubMed ID: 10399835
[TBL] [Abstract][Full Text] [Related]
3. Different inhibitory effects of 5-S-glutathionyl-beta-alanyl-L-dopa (5-S-GA-L-D) analogues on autophosphorylation and substrate phosphorylation of Src protein tyrosine kinase.
Zheng ZB; Nagai S; Iwanami N; Suh DY; Kobayashi A; Hijikata M; Natori S; Sankawa U
Chem Pharm Bull (Tokyo); 1999 Jan; 47(1):136-7. PubMed ID: 9987835
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of protein tyrosine kinase by 5-S-GAD, a novel antibacterial substance from an insect.
Hijikata M; Kobayashi A; Leem JY; Fukasawa H; Uehara Y; Natori S
Biochem Biophys Res Commun; 1997 Aug; 237(2):423-6. PubMed ID: 9268727
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of 5-S-GAD on phosphorylation of V-SRC and BCR-ABL tyrosine kinase.
Leem JY; Park HY; Fukazawa H; Uehara Y; Natori S
Biol Pharm Bull; 1998 Jul; 21(7):784-5. PubMed ID: 9703270
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.
Showalter HD; Sercel AD; Leja BM; Wolfangel CD; Ambroso LA; Elliott WL; Fry DW; Kraker AJ; Howard CT; Lu GH; Moore CW; Nelson JM; Roberts BJ; Vincent PW; Denny WA; Thompson AM
J Med Chem; 1997 Feb; 40(4):413-26. PubMed ID: 9046331
[TBL] [Abstract][Full Text] [Related]
7. Benzamides and benzamidines as specific inhibitors of epidermal growth factor receptor and v-Src protein tyrosine kinases.
Asano T; Yoshikawa T; Usui T; Yamamoto H; Yamamoto Y; Uehara Y; Nakamura H
Bioorg Med Chem; 2004 Jul; 12(13):3529-42. PubMed ID: 15186837
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and cellular effects of c-Src kinase-selective pyrido[2, 3-d]pyrimidine tyrosine kinase inhibitors.
Kraker AJ; Hartl BG; Amar AM; Barvian MR; Showalter HD; Moore CW
Biochem Pharmacol; 2000 Oct; 60(7):885-98. PubMed ID: 10974196
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine phosphorylation of I-kappa B kinase alpha/beta by protein kinase C-dependent c-Src activation is involved in TNF-alpha-induced cyclooxygenase-2 expression.
Huang WC; Chen JJ; Inoue H; Chen CC
J Immunol; 2003 May; 170(9):4767-75. PubMed ID: 12707358
[TBL] [Abstract][Full Text] [Related]
10. A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling.
Waltenberger J; Uecker A; Kroll J; Frank H; Mayr U; Bjorge JD; Fujita D; Gazit A; Hombach V; Levitzki A; Böhmer FD
Circ Res; 1999 Jul; 85(1):12-22. PubMed ID: 10400906
[TBL] [Abstract][Full Text] [Related]
11. Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiation.
Li Z; Hosoi Y; Cai K; Tanno Y; Matsumoto Y; Enomoto A; Morita A; Nakagawa K; Miyagawa K
Biochem Biophys Res Commun; 2006 Mar; 341(2):363-8. PubMed ID: 16414009
[TBL] [Abstract][Full Text] [Related]
12. Pyrazolo pyrimidine-type inhibitors of SRC family tyrosine kinases promote ovarian steroid-induced differentiation of human endometrial stromal cells in vitro.
Maruyama T; Yamamoto Y; Shimizu A; Masuda H; Sakai N; Sakurai R; Asada H; Yoshimura Y
Biol Reprod; 2004 Jan; 70(1):214-21. PubMed ID: 14522827
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of growth factor-mediated tyrosine phosphorylation in vascular smooth muscle by PD 089828, a new synthetic protein tyrosine kinase inhibitor.
Dahring TK; Lu GH; Hamby JM; Batley BL; Kraker AJ; Panek RL
J Pharmacol Exp Ther; 1997 Jun; 281(3):1446-56. PubMed ID: 9190882
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting Src family tyrosine kinase activity blocks glutamate signalling to ERK1/2 and Akt/PKB but not JNK in cultured striatal neurones.
Crossthwaite AJ; Valli H; Williams RJ
J Neurochem; 2004 Mar; 88(5):1127-39. PubMed ID: 15009668
[TBL] [Abstract][Full Text] [Related]
15. Nicotine-induced phosphorylation of Akt through epidermal growth factor receptor and Src in PC12h cells.
Nakayama H; Numakawa T; Ikeuchi T
J Neurochem; 2002 Dec; 83(6):1372-9. PubMed ID: 12472891
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of N-beta-alanyl-5-S-glutathionyl-3,4-dihydroxyphenylalanine, a novel antibacterial substance of Sarcophaga peregrina (flesh fly).
Leem JY; Nishimura C; Kurata S; Shimada I; Kobayashi A; Natori S
J Biol Chem; 1996 Jun; 271(23):13573-7. PubMed ID: 8662858
[TBL] [Abstract][Full Text] [Related]
17. EGFR plays a pivotal role in the regulation of polyamine-dependent apoptosis in intestinal epithelial cells.
Ray RM; Bhattacharya S; Johnson LR
Cell Signal; 2007 Dec; 19(12):2519-27. PubMed ID: 17825525
[TBL] [Abstract][Full Text] [Related]
18. 4-Anilino-7,8-dialkoxybenzo[g]quinoline-3-carbonitriles as potent Src kinase inhibitors.
Berger DM; Dutia M; Birnberg G; Powell D; Boschelli DH; Wang YD; Ravi M; Yaczko D; Golas J; Lucas J; Boschelli F
J Med Chem; 2005 Sep; 48(19):5909-20. PubMed ID: 16161995
[TBL] [Abstract][Full Text] [Related]
19. Target modulation by a kinase inhibitor engineered to induce a tandem blockade of the epidermal growth factor receptor (EGFR) and c-Src: the concept of type III combi-targeting.
Rao S; Larroque-Lombard AL; Peyrard L; Thauvin C; Rachid Z; Williams C; Jean-Claude BJ
PLoS One; 2015; 10(2):e0117215. PubMed ID: 25658745
[TBL] [Abstract][Full Text] [Related]
20. Damnacanthal is a highly potent, selective inhibitor of p56lck tyrosine kinase activity.
Faltynek CR; Schroeder J; Mauvais P; Miller D; Wang S; Murphy D; Lehr R; Kelley M; Maycock A; Michne W
Biochemistry; 1995 Sep; 34(38):12404-10. PubMed ID: 7547985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
